Get an email when this journal's indexing changes
Added to or removed from Scopus, Web of Science, ABDC, DOAJ, FT50, UT Dallas or ONOS. One confirmation click; unsubscribe anytime.
Frontiers in Clinical Drug Research - CNS and Neurological Disorders is Scopus-indexed (Q3, CiteScore 1.6). Published by Bentham Science Publishers.
Checked against the index lists dated .
ISSN 2214-7527Verify ISSN ↗2451-8883Verify ISSN ↗
Publisher: Bentham Science Publishers
Cost to publish: No APC data — check the publisher
| Subject area | Rank | Pctile | Q |
|---|---|---|---|
| Pharmaceutical Science | 125 / 191 | 34th | Q3 |
| Pharmacology (medical) | 196 / 278 | 29th | Q3 |
| Neurology (clinical) | 300 / 403 | 25th | Q3 |
Not listed in: Web of Science, DOAJ, ABDC, ABS / AJG, FT50, UT Dallas, ONOS (subscription), ONOS (APC covered)
Yes — actively indexed in Scopus, coverage 2020–2024, best quartile Q3, CiteScore 1.6.
Frontiers in Clinical Drug Research - CNS and Neurological Disorders is Q3 in Pharmaceutical Science (rank 125 of 191), Q3 in Pharmacology (medical) (rank 196 of 278) and Q3 in Neurology (clinical) (rank 300 of 403), by CiteScore 2025.
Frontiers in Clinical Drug Research - CNS and Neurological Disorders is not in the Web of Science Core Collection (SCIE, SSCI, AHCI or ESCI), so Clarivate publishes no Journal Impact Factor for it. Its Scopus CiteScore is 1.6, quartile Q3, 34th percentile. Any "impact factor" quoted elsewhere is not the Clarivate metric. Its SCImago Journal Rank (SJR, a free Scopus-based metric) is 0.133, quartile Q4, with an H-index of 2.
Frontiers in Clinical Drug Research - CNS and Neurological Disorders is published by Bentham Science Publishers. Its print ISSN is 2214-7527 and its online ISSN is 2451-8883.
No — it is not currently in the Web of Science core collections (SCIE, SSCI, AHCI or ESCI).
No — it is not registered as an open-access journal in DOAJ or Scopus.
Frontiers in Clinical Drug Research - CNS and Neurological Disorders has an h-index of 4 and a 2-year mean of 1 citations per paper (OpenAlex). Its Scopus CiteScore is 1.6, quartile Q3. On 2-year citations it ranks #114 of 177 Scopus journals in Pharmaceutical Science.
Frontiers in Clinical Drug Research - CNS and Neurological Disorders published 10 papers in 2024; its busiest recent year was 2020 with 19. 2026* is the year so far.
h-index, i10-index and 2-year mean citedness are open, licence-clear metrics from OpenAlex — not a proprietary impact factor. The subject rank counts only journals that OpenAlex has a figure for; it is not a Scopus or Clarivate ranking. Updated 2026-10-14.
Scopus status: Active. No retracted papers are recorded. The Problematic Paper Screener flags none of its papers. These are indicators to check, not findings against the journal.
Retractions from OpenAlex; flags from the Problematic Paper Screener (Cabanac, Labbé & Magazinov, CC BY), 2026-09-21 export. A flag marks a paper for a closer look; it is not a finding against the journal.
Index data is curated from public sources (Scopus, Web of Science, ABDC, FT50, UT Dallas, DOAJ). CiteScore and quartiles reflect the latest available Scopus release. Always verify a journal's current status on its official source before submitting.
Comments load as you scroll here.